In both the FIDELITY analysis and FINEARTS-HF, potassium management strategies, such as pausing treatment when serum potassium levels exceeded 5.5 mmol/L and resuming therapy once levels dropped below 5.0 mmol/L, were effective in preventing hyperkalemia-related adverse events
We know obesity is associated with pseudo hypogonadism not pathological
State officials acknowledge the impact on low-income residents and say future coverage could be reconsidered if drug pricing becomes more affordable
Projections indicate a compound annual growth rate of 8-10% through 2028 as consumers seek alternatives to traditional retinoids and botulinum toxin-based treatments
But Terri ensures her training combines sculpting and cardio and has honed her technique for years
About the study The present study aimed to compare the on-treatment weight loss due to semaglutide and tirzepatide among overweight or obese individuals in a clinical population, as it is unclear whether semaglutide and tirzepatide treatments in the clinical setting reflect the weight loss observed in randomized clinical trials